Delusions of Parasitosis and Morgellons: What the Evidence Shows in 2026

EVIDENCE REVIEW · v0.23 · UPDATED NOVEMBER 11, 2026

What separates a distressing skin sensation, a visible fiber and a delusion? The answer matters to people whose symptoms have been described as either Morgellons or delusions of parasitosis. Those labels can refer to overlapping experiences, but different authors use them to make different claims.

The prevailing clinical interpretation treats Morgellons as a presentation of delusional infestation (DI). A smaller body of literature, including Lai and colleagues’ 2018 review, argues for a distinct filament-associated condition.^{[2][15][19][20]} This article uses Lai’s distinction between observations, mistaken beliefs, overvalued ideas and delusions to examine physical findings and infestation beliefs separately. That analytical distinction does not establish a separate disease or an infectious cause.^[1][2][19]

Scope: A targeted narrative review of selected studies, reviews and clinical guidance. The original literature search ran through October 28, 2026; source checks and editorial revisions continued through November 11. External clinical feedback informed this revision. The conclusions are the author’s own.

Clinical assessment and the distinction in Lai’s review

Lai and colleagues distinguish observations, mistaken beliefs, overvalued ideas and delusions.^[19] Recommended clinical assessment likewise examines the material and the belief attached to it; bringing a specimen is not itself a diagnosis. The British Association of Dermatologists (BAD) guideline recommends a full history and physical examination, inspection of submitted samples and appropriate investigation of underlying conditions.^[1][2]

The review also argues that Morgellons is distinct from DI and favors a spirochetal association, drawing on Middelveen’s studies and 2018 review.^[19]

Lai’s distinct-condition position is a minority interpretation of the evidence.^[15][19][20] We retain the review’s separation of a proposed physical finding from a psychiatric assessment because they answer different questions: what material is present, and what does the person believe it means? In Middelveen’s proposed definition, clinician-observed embedded or projecting filaments identify the presentation; DI requires a delusional infestation belief assessed in clinical context.^[1][2][4] This is a framework for evaluating claims, rather than a validated diagnostic boundary.

The filament criterion has not been validated as a reliable way to distinguish a separate disease from DI. A physical finding and a delusional interpretation can coexist in one person. Lai calls for further investigation of a possible spirochetal association, but the review’s use of the same underlying filament and infection studies does not provide an independent clinical replication.^[19] The rationale for examining the reported filament-associated skin findings is to make the specimen question testable; it supplies no presumption that the disease or infectious hypothesis is correct.

A physical finding can be a characteristic without causing symptoms. Its origin, normality and clinical significance still need testing.

Material associated with skin may include surface contamination, ordinary tissue-derived structures such as hair, or a pathological tissue product. Origin must be established in the particular specimen. Even confirmed internal production does not show that a structure is abnormal or specific to a disease.^[5][6][8] Comparisons with unaffected people and people with other skin conditions would help distinguish normal variation from pathology. A finding could mark a skin process without itself causing pain, itching or crawling sensations.

Hylwa and Ronkainen’s 2018 review, Delusional infestation versus Morgellons disease, takes the competing DI position.^[20] Beuerlein and colleagues’ 2021 systematic review also favored a psychiatric interpretation, while describing the etiologic evidence as correlative.^[15] Hylwa and Ronkainen’s full text was unavailable for this review; its abstract is used only to identify its position.

What does delusions of parasitosis mean?

“Delusions of parasitosis” is an older term. “Delusional infestation” is broader: the believed agent can be a parasite, another organism or inanimate material such as fibers. A fixed infestation belief maintained despite contrary medical evidence is central; merely reporting material is not the same finding.^[1][2]

The distinction between primary and secondary delusional infestation also matters. Primary delusional disorder and infestation beliefs associated with another medical, psychiatric or substance-related condition are not interchangeable diagnostic categories.^[1][2]

Coetzee and colleagues distinguish formication—the sensation of crawling, biting or stinging—from a fixed belief about what causes it. Their review also describes excoriations, erosions, ulcers, pigmentation changes and scars in delusional infestation. Physical damage therefore does not, on its own, resolve the psychiatric question.^[3]

The BAD guideline requires clinical assessment, consideration of other causes and examination of patient-provided material before diagnosing DI. The content and persistence of the belief require assessment too.^[1] These safeguards are part of recommended psychiatric and dermatologic practice. Lepping’s outcomes cohort provides a concrete example: two of the 465 referred patients had a genuine infestation and were excluded from the DI outcomes analysis.^[16]

Squire and colleagues’ combined tropical medicine and psychiatry clinic describes taking a detailed medical, travel and psychiatric history, performing a physical examination and arranging laboratory assessment of submitted samples. Testing is guided by the clinical and travel history, and the service also develops treatment plans for people who do not have DI.^[36] This approach evaluates genuine infestation, other medical explanations and psychiatric criteria together.

Why Morgellons does not have one agreed meaning

In the psychiatric framing, Morgellons describes a presentation of delusional infestation in which fibers or other material feature in the infestation belief. In the competing framing, Middelveen and colleagues propose a condition defined by filaments embedded in or projecting from skin, and argue for an infectious association. Their 2018 review also acknowledges the need for a universally accepted definition.^[2][4]

That disagreement is substantive. One framework centers on the nature of a belief; the other centers on a proposed physical finding. Using the same word does not ensure that two studies recruited the same population.

Question	Delusional infestation	Morgellons
What is central?	A fixed infestation belief unsupported by the medical evidence, assessed in context.[1][2][3]	Usage differs: a fiber-focused infestation belief, or a proposed filament-associated condition.[2][4][19]
Can there be real skin damage?	Yes. Lesions can occur.[3]	Lesions feature in the infection-model literature, although definitions and recruitment criteria differ.[4][7]
Does it explain the cause?	DI identifies a delusional-infestation presentation; its underlying cause is assessed separately (primary versus secondary).[1][2]	The term alone does not resolve the disputed physical, infectious and psychiatric interpretations.[4][5]

The literature uses both “fiber” and “filament.” Here, each source’s terminology is retained. The terminology alone leaves biological origin unresolved.

Separate four questions before comparing the presentations

• Sensation: What does the person feel—itching, crawling, pain or something else?
• Observation: What skin change or material was actually seen, where, and by whom?
• Interpretation: What does the person believe explains it? Describe the strength and persistence of conviction, openness to alternative explanations and response to evidence over time.^[19]
• Cause: What evidence connects the findings to a particular mechanism?

These four questions are our editorial adaptation of the distinctions above.^[19] They organize what needs explaining; they are not a diagnostic test or a claim that sensations distinguish the conditions. Connecting a particular material to symptoms requires its own evidence.

A genuine observation can receive an unsupported explanation. A psychiatric interpretation can also be inadequately documented.

What the earlier studies can establish

Pearson: a broad unexplained-dermopathy population

Pearson and colleagues identified 115 case patients; 41 underwent clinical evaluation. Of the 115, 104 were identified through electronic health records and 11 through self-identification. Eligibility required reported material emerging from the skin together with lesions, abnormal sensations or both—not a prior diagnosis of delusional infestation. The CDC/Kaiser study found no common underlying cause. Most analyzed material was cellulose consistent with cotton.^[5]

The authors reported clinical and epidemiologic similarities with DI and discussed therapies used for similar conditions. Those findings do not establish that every participant had delusional infestation. The authors explicitly left open whether the findings represented a new condition or wider recognition of an existing condition such as delusional infestation. Nor did “no common cause” mean no participant had an infection: bacterial and fungal findings were reported, including findings consistent with secondary infection.^[5]

Pearson’s Lyme testing found one positive screening enzyme immunoassay and one borderline result, but no positive confirmatory IgG Western blots.^[5] These findings provide no support for a common Lyme-associated explanation in the tested cohort. Screening reactivity should not be presented as confirmed Lyme disease. The study’s cross-sectional design, lack of a comparison group and symptom-based case definition limit broader inference about association or causation in differently defined populations.^[5]

For the recruitment, specimen and inference questions, see our audit of the CDC study.

Specimen series: Mayo and the UK reference laboratory

Hylwa and colleagues reviewed 108 patients classified as having DI using inclusion criteria that ranged from overvalued ideas to fixed, unshakable beliefs. Eighty underwent biopsies, 80 supplied specimens and 52 did both. No biopsy supplied evidence of infestation. Submitted material included skin debris, textile fibers and insects; a suspected pubic louse was judged insufficient to explain the patient’s wider complaints.^[17]

Foster and colleagues described 147 Mayo patients seen in 2001–2007. Our generalization caveat concerns uses beyond a DI-selected population, rather than a requirement that these studies estimate DI among all fiber reporters. Hylwa’s paper explicitly selected 108 from 147 DI patients at the same clinic in those years. These reports therefore concern overlapping patients, rather than independent samples. Foster reported fibers in 29 of 143 patients with the relevant information. These findings describe patients recruited as having DI. That selection leaves the frequency of DI among unselected fiber reporters unknown.^[17][18]

Garcia-Mingo and colleagues prospectively catalogued 138 samples from 123 patients at the UK Parasitology Reference Laboratory. They identified no human parasites.^[23] This adds a laboratory setting beyond Mayo. A finding about submitted specimens still leaves the patient’s belief and the frequency of DI among unselected fiber reporters as separate questions.

Clinical series from the infection-model group

Savely and Stricker’s 2010 fiber group included 122 patients with subcutaneous fibers observed on examination. The comparison group comprised 60 volunteers recruited from the first author’s current and former Lyme patients.^[21] This selected comparison describes symptom differences within a practice; it cannot show whether Lyme is more common in Morgellons than in an appropriate non-Lyme-selected comparison population.

Fesler and colleagues’ 2018 study screened 1,000 Lyme-seropositive patients and classified 60 as Morgellons using microscopic fibers in lesions or beneath unbroken skin.^[22] Because everyone screened already tested positive for Lyme, the study cannot show that Lyme is more common in Morgellons. The 1,000 were screened patients, not 1,000 Morgellons patients.

The filament studies: observations and their interpretation

Middelveen and colleagues’ 2012 three-case report states that a practitioner confirmed fibers in place, beneath unbroken skin, in all three patients. It also reports normal neuropsychiatric evaluations in two patients and reactive depression in the third.^[32] These case histories support examining the physical finding and the psychiatric question separately.

For laboratory examination, patients themselves collected and submitted specimens. The neuropsychiatric assessment protocol is unspecified.^[32] This small report belongs to the same research program as the later filament work, rather than providing independent replication.^[6][32] These three case histories leave the psychiatric status of other filament-associated presentations open.

Middelveen and colleagues’ 2013 histology paper examined non-biopsy callus specimens from four women. The work included histological sectioning, cytokeratin immunostaining, trichrome staining and electron microscopy. The authors interpreted the findings as evidence of keratin- and collagen-containing filaments produced by skin cells. Bovine digital dermatitis specimens provided a comparison; there was no human delusional-infestation comparison group.^[6]

Middelveen and colleagues’ 2015 study reported Borrelia detection in 24 of 25 selected patients. Its design did not compare that frequency with an independently assessed DI cohort. The authors presumed their filament criterion excluded primary DI. Testing that presumed exclusion would require an independent DI assessment.^[7]

What the 24-of-25 result measures

The combined result used PCR and/or in-situ hybridization across patient-derived specimens, including tissue and cultures. Patients were enrolled consecutively as they volunteered; five had appeared in earlier reports. The study reports blinded laboratory testing and technical controls, including normal skin samples. Those safeguards differ from a prospectively recruited DI comparison group.^[7]

Several laboratories tested material within this study. That corroboration is different from an independent team recruiting a new cohort and replicating the whole study. The papers reviewed here do not supply that independent replication of the proposed filament–Borrelia causal model.^{[6][7][8][10]}

Our critical comparison of skin-material research examines the wider specimen-context problem.

Middelveen and colleagues’ 2020 paper proposed a classification and staging system and included technical controls. Figure 7 presents sections the authors interpret as filaments with basal-layer origin and keratinocyte composition at their attachment.^[8] That is a tissue-origin interpretation, rather than a test of diagnostic specificity. Our assessment separates human origin, abnormality and clinical association. Comparisons with ordinary hair and keratin, other skin disorders and independently assessed DI would help test those steps.

What the 2020 tissue images report

Figure 7 shows sections at 200×, 400× and 1000× magnification. The authors describe the base of attachment and lower shaft as keratinocytes continuous with the basal layer.^[8]

Specimens mainly consisted of thickened callus material removed from lesions. McClain Laboratories performed histological processing; the paper reports blinded processing and normal-skin controls, alongside positive and additional negative immunostaining controls.^[8]

The anti-Borrelia antibody was intentionally selected for broad spirochetal reactivity; the paper acknowledges cross-reactivity with other spirochetes.^[8] These safeguards and limits belong in evaluating the reported staining. They do not substitute for a comparison testing whether the filament finding distinguishes Morgellons from DI.

A material match and a psychological explanation are separate findings

Roncati and colleagues’ 2016 report compared filaments from one patient’s lesions with environmental material.^[30] In their later letter, Roncati and Piscioli described human or pet hairs and plastic fibers matching material from indoor air and a washing-machine filter. They argued that the match could be explained only by the patient introducing the material beneath the skin, and favored a psychological origin.^[31]

The letter links a material match to a mechanism of insertion and then to psychogenesis.^[31] Our assessment is narrower: matching material supports an environmental source, but the match alone does not establish intentional insertion or a psychological cause. Those inferences require their own evidence, just as a protein finding alone does not establish an infectious cause.

Ohn: a real observation does not settle the explanation

Ohn and colleagues described a patient with patches and erosions elsewhere, but took a biopsy from intact forearm skin. They photographed a single black fiber protruding from the specimen’s dermal side in Figure 3. This was a clinician-observed specimen finding; Figure 1 contains the patient’s magnified photographs. The fiber was not analyzed and could not be identified after routine tissue processing; the authors suggested solvents might have dissolved it. Histology was otherwise normal apart from mild superficial perivascular lymphocytic inflammation.^[9]

The authors interpreted the case as delusional infestation. The observed fiber’s composition and origin remain unknown.^[9] Our assessment is that a single unidentified fiber establishes neither tissue origin nor clinical significance. Repeated observations with recoverable material would help test those claims. The observation remains part of the record alongside the authors’ psychiatric interpretation.

What changed in the 2026 literature?

A fiber review argues for cellular origin

Middelveen, Fesler and Stricker’s The Cellular Origin of Morgellons Disease Fibers argues for cellular origin while listing etiology among the unresolved questions. One protein match was ambiguous between serum albumin and keratin; the authors favored keratin using a hair-like image. The review provides no validated diagnostic comparison with DI.^[10]

One imaged fiber, several analyzed fibers

In the review’s account of a 2006 analysis, electron microscopy concerned one hair-like fiber; proteomic analysis used several ground together. A protein band matched both serum albumin and keratin II. The authors favored keratin using the hair-like appearance. The account came through a 2025 email.^[10]

The report leaves the correspondence between the imaged fiber and the pooled protein result unresolved. See our source audit of the Odyssey review.

The psychodermatology review makes a further argument

In Morgellons Disease and Psychodermatology, the same three authors distinguish observations, mistaken beliefs and delusions, and acknowledge genuine delusions in a subset of patients. They also argue that sensitive testing reliably detects tick-borne infection in Morgellons patients. On that premise, they reject classification of Morgellons as a delusional disorder.^[11]

An infection finding leaves three possibilities to assess. The authors’ position is that patients accurately describe an infection-related skin process.^[11] Alternatively, infection could contribute to a secondary delusion, or coexist with an unrelated delusion.^[1][2] Distinguishing them requires evidence about the specific belief: does what the person reports—such as fibers emerging—match what the infection demonstrably produces? Establishing infection alone leaves that question open.

DSM-5-TR’s exclusion, as quoted in the 2026 review, concerns a disturbance attributable to another medical condition.^[11] The primary/secondary distinction means that a medically caused delusional symptom can exist even when primary delusional disorder is the wrong diagnostic category.^[1][2]

The review’s observation-versus-belief distinction is useful. Its infection premise needs independent support before it can justify excluding DI.^[11] The proposed physical finding and any delusional interpretation therefore require separate clinical assessment.

A microbial preprint adds a different approach

Lambert and Kindschuh’s April 2026 preprint reports metagenomic differences between lesion material and unaffected-skin swabs from five family members. It describes a lesion-associated microbial signature and calls for larger studies.^[24] It does not report a Borrelia-specific read-detection result. That is neither a reported positive result nor evidence of absence. The work has not been peer reviewed.

What the preprint reports—and leaves unresolved

The preprint compares pooled lesion material with postauricular swabs.^[24] Our assessment is that a single household and different specimen types and sites limit specificity: differences could reflect sampling, damaged skin or secondary colonization. No DI comparison group was included.^[24]

The authors list a Columbia University affiliation.^[24] This is an exploratory study by a separate author team, rather than a replication of the full proposed filament–Borrelia model. Its different sampling sites and specimen types, single-household recruitment and lack of a DI comparison group leave the specificity of the reported signature unresolved.^[24]

An international consensus addresses diagnosis and care

Kemperman and colleagues’ 2026 international Delphi study reached consensus on 20 of 22 statements. Its recommendations distinguish primary and secondary delusional infestation, support examining patient-provided material and address coordinated dermatologic and mental-health care. This is structured expert consensus—not a blinded experiment testing whether filament-defined Morgellons and delusional infestation are the same condition.^[12]

A two-center cohort records fiber-themed beliefs

Hauptman and colleagues reviewed 155 patients diagnosed with delusional infestation across two medical centers. Fifteen had a fiber-related theme. This documents fiber-themed beliefs within clinically diagnosed DI; it leaves the proportion of all fiber reporters with DI unknown. The cohort was selected for delusional infestation, rather than recruited from all people using the Morgellons label.^[13]

Brain imaging: evidence about DI mechanisms

Structural and functional MRI studies report brain differences in selected groups of patients with DI.^[33][34][35] The proposed explanation concerns networks involved in bodily sensation, sensory integration and evaluating whether perceptions fit expectations. Disturbed interaction between incoming sensory information and prior expectations could help explain abnormal perceptions and persistent infestation beliefs.^[35] This gives the psychiatric formulation a plausible biological mechanism while leaving its causal details to be tested.

What three neuroimaging studies report

Huber and colleagues’ 2008 MRI series assessed nine patients. Five had a medical secondary form, three had pre-existing psychiatric illness and one had a primary delusional disorder. Striatal lesions occurred in four assessable medical-secondary cases; they were absent in the primary case and the psychiatric-secondary cases. The authors called the findings preliminary and requested larger studies.^[33]

Eccles and colleagues’ 2015 functional MRI study reported altered responses to infestation-relevant stimuli and differences in self-representation. The authors proposed a model for maintaining abnormal skin sensations.^[34]

Huber and colleagues’ 2018 structural MRI study compared 18 DI patients, 19 with non-somatic delusional disorders and 20 healthy controls. The DI group included primary and secondary cases. All DI patients received antipsychotics.^[35]

Region-of-interest and network analyses found differences between DI and the other delusional-disorder group; the whole-brain comparison between those groups was not statistically significant. Sixteen DI patients and 16 controls had appeared in earlier analyses.^[35]

The authors relate the frontostriatal and insular findings to evaluation of sensory input and probabilistic reasoning: difficulty reconciling expectations with bodily sensations could contribute to delusional conviction.^[35] They adjusted for age and sex but acknowledged group age differences, patient heterogeneity and possible long-term medication effects. They also explicitly describe the functional mechanism as speculative because it is inferred from structural data.^[35]

The 2008 and 2015 summaries above rely on primary-study abstracts; the 2018 paper was read in full. These studies characterize clinically selected groups and report no separate filament-defined comparison group. Brain associations inform possible mechanisms while leaving the relationship between the proposed filament-defined category and DI unresolved.

Does improvement with treatment settle the diagnosis?

Lepping and colleagues defined remission as a fall of at least three points on the seven-point, clinician-rated Clinical Global Impression severity scale (CGI-S). The scale assessed global clinical severity, beyond delusional intensity alone. A fall of this magnitude represents substantial clinical improvement and can reach a symptom-free or near-symptom-free level, depending on the starting score. Remission is reported here using the study’s change-score definition, rather than as a separately measured symptom-free rate.^[16]

Of 281 patients who attended at least twice, 69 met the remission threshold and 108 more improved by one or two points. Recorded outcomes differed by follow-up status: 65 of the 151 patients who completed follow-up reached remission (43.0%), compared with 4 of 130 who attended at least twice but were later lost to follow-up (3.1%).^[16]

How the Lepping numbers fit together

Of 465 referrals, 121 were excluded from analysis: 56 never attended, 38 had missing data, 16 died during treatment, 9 were still in treatment and 2 had a genuine infestation. Of the remaining 344, 63 attended once, 130 attended at least twice before being lost to follow-up, and 151 completed follow-up with a planned discharge. For the 63 single attenders, their only severity rating was carried forward.^[16] Retaining this group avoids restricting the broader analysis to patients who returned. Carrying their baseline ratings forward records no measured improvement and lowers the apparent improvement relative to excluding them; it does not establish their subsequent clinical course. This distinction matters when comparing the broader attendance group with patients who completed follow-up.

The abstract states that “108 (38.4%) had a response or remission (n = 69; 24.6%).” Table 1 lists separate groups: 108 responses and 69 remissions. Adding them gives 177 of 281 repeat attenders (63.0%) with improvement, broadly consistent with the lay summary’s description of roughly two-thirds. Reading 38.4% as the combined rate would understate the improvement shown in the table.^[16]

This was a retrospective observational comparison. Medication adherence was self-reported, and treatment was not randomly assigned. These comparisons show associations rather than isolating the effects of medication or engagement. The paper describes randomized trials as difficult in this population and prospective follow-up as challenging but potentially possible.^[16]

Leung and Koo’s 2026 clinical perspective acknowledges that high-quality comparative evidence for pharmacologic treatment remains limited. It presents clinical experience and opinion.^[14]

The 2019 Cochrane review found no eligible randomized trials of primary DI treatment in its search through March 2019.^[26] Lu and colleagues’ 2022 systematic review included 15 case series involving 280 patients, with subjective outcomes and difficulty separating primary from secondary DI.^[27] These limits concern precision and causal inference; they do not erase the improvements reported in the clinical series.

What improvement with different treatments can show

Yan and Jorizzo’s retrospective Morgellons series included 24 patients receiving trifluoperazine and counseling. Fifteen achieved at least 50% improvement; seven returned to baseline function under the authors’ definitions.^[28] Selection for repeat visits, combined management and the absence of a control group limit causal interpretation.

Zhang and colleagues reported improvement with doxycycline in one Morgellons-labeled patient. Lyme IgM and IgG were negative, and previously prescribed risperidone and lithium continued.^[29] Concurrent treatment leaves the reason for improvement unresolved.

The Cochrane discussion describes older small pimozide comparison studies but reports that neither used random allocation.^[26] Outcomes, comparators and eligibility need to accompany any treatment claim.

Middelveen and colleagues’ 2018 review reports antibiotic improvement while acknowledging that the evidence was anecdotal and controlled antibiotic-treatment studies had not been conducted.^[4] Applying the same causal standard does not make the evidence equally strong. Antipsychotic treatment has clinical series and follow-up data here; the antibiotic reports cited here are anecdotal or single-case observations.^{[16][27][4][29]} Improvement deserves accurate reporting, while attribution to a particular cause remains a separate question. That standard applies to both antibiotic and psychiatric-medication reports.

Watch: Ginger Savely on interpreting treatment response

https://www.youtube.com/watch?v=I9m19lDbKcU&t=834s

In this 2017 interview with Jeremy Murphree, Ginger Savely explains why improvement after an antibiotic does not, by itself, prove bacterial causation. Start at 13:54 for the lead-in; the specific caution appears around 14:10. Savely coauthored the clinical series discussed above.^[21] This is a practitioner discussion, not a controlled treatment comparison, and it predates the 2026 research reviewed here.

What research would make the difference clearer?

Akbarialiabad and colleagues’ 2025 review searched four databases and found no randomized trial of a Morgellons treatment. It called for standardized diagnostic criteria, multicenter observational studies and subsequent trials.^[25] The central research task is a comparison that can test the competing explanations without building either conclusion into recruitment.

• Define the populations in advance. Separate self-applied labels, clinician-observed findings and independently assessed infestation beliefs.
• Compare appropriate groups. Include people meeting the proposed filament definition, people independently assessed as having DI, unaffected controls and relevant skin-condition controls. Determine whether the same structures occur in each group.
• Preserve specimen context. Record collection, handling, location and whether microscopy and material analysis concern the same object.
• Use independent assessments. Blind laboratory interpretation where feasible and assess psychiatric criteria separately from agreement with a favored causal model.
• Report follow-up honestly. Record skin findings, distress, function, treatment exposure and missing outcomes without turning loss to follow-up into a result.

These priorities concern study design and reporting. Existing safeguards should be credited, and their limits specified.

Why independent comparisons matter

The DI literature draws on multiple clinical teams, specialties and settings, including UK guidance and multidisciplinary clinics, US clinical cohorts, a UK reference laboratory and neuroimaging studies.^{[1][13][16][17][18][23][35][36]} Some reports share authors or patients, as noted for the Mayo cohorts and the imaging samples. Those specific dependencies matter when counting independent evidence. They do not make the wider DI literature equivalent to the smaller, recurring author group responsible for much of the proposed filament–Borrelia model.

Lai’s separate-author review supports the distinct-condition position but interprets the same primary filament and infection studies; it does not add an independent replication cohort.^[19] This review identified no independent replication of the full proposed filament–Borrelia causal model in the studies assessed.^{[6][7][8][10]} That gap weakens the case for a distinct infectious disease. Evidence should be weighed by study design, appropriate controls, independent samples and replicated findings, rather than by publication counts or author overlap alone. The prevailing clinical interpretation remains DI, with individual diagnosis requiring the clinical assessment described above.^{[1][2][15][20]}

What the evidence means for Morgellons and delusional infestation

The prevailing clinical interpretation places Morgellons within DI. A distinct filament-associated disease remains an unvalidated hypothesis, and an infectious cause has not been established.^{[2][4][15][19][20]} We use Lai’s distinctions to keep specimen findings, the patient’s interpretation and causal explanations separately assessable. This supports investigating the reported filament-associated skin findings without assuming that they define a separate disease or that everyone reporting them has DI.

Clinical guidance and the international Delphi consensus support coordinated medical, dermatologic and mental-health assessment for DI.^[1][12] The combined-clinic description shows how this can include medical and travel history, examination and laboratory assessment of submitted material.^[36] A careful psychiatric formulation therefore includes investigation of physical symptoms and possible alternative causes. Consensus recommendations guide care, while questions about the proposed filament criterion require direct diagnostic validation.

The unresolved empirical question is who meets the proposed filament definition and whether that finding reliably distinguishes a group from DI. That includes distinguishing skin-produced filaments from environmental material in the particular specimen.^{[5][6][17][30][31]} That diagnostic validation is the study still needed. Pearson left a new condition versus an existing condition such as DI unresolved.^[5] Estimating how many unselected fiber reporters have DI requires recruitment beyond DI-selected cohorts.^[13][17][18] The three-case report’s neuropsychiatric findings warrant attention, with its small size and undescribed assessment protocol kept in view.^[32] Our article, The Stain That Would Settle It, examines the specimen question: what is the material, and what tissue process placed it there?

An infectious cause requires evidence connecting a pathogen to the particular skin process. A diagnosis of DI requires evidence about a delusional infestation belief in its clinical context.^[1][2] Neither the Morgellons label nor a photograph settles an individual case. The useful research task is to characterize the material, establish its origin and significance, and assess the associated belief independently. That approach gives clinical findings and psychiatric evidence their appropriate weight.

Related reading

• Morgellons or Delusional Infestation? The Difference Must Be Investigated
• Interpreting Skin Material in Morgellons Research
• The evidence for Morgellons without skin lesions
• Morgellons glossary
• The Stain That Would Settle It
• Morgellons Fibers After Twenty Years: Reading the New Middelveen–Stricker Review
• The CDC Morgellons Study: What It Found—and What It Couldn’t Prove

References